Skip to main content

Find Clinical Trials

Home
Conditions
EGFR Sensitive Mutation

Clinical trial condition

EGFR Sensitive Mutation

Explore clinical trials studying EGFR Sensitive Mutation. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

EGFR Sensitive Mutation trial results

Recruiting

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

NCT06041776

Conditions: Adjuvant Therapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Peking University International Hospital Beijing, China

Jiangsu Cancer Hospital Nanjing, China

Shanghai chest hospital Shanghai, China

View Trial Details

Not Yet Recruiting

A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody

NCT06048315

Conditions: Anlotinib, EGFR Sensitive Mutation, Lung Cancer, +9 more
Locations: Not specified

View Trial Details